Setareh Seyedkazemi - Net Worth and Insider Trading

Setareh Seyedkazemi Net Worth

The estimated net worth of Setareh Seyedkazemi is at least $36,229 dollars as of 2024-05-26. Setareh Seyedkazemi is the Chief Development Officer of Adverum Biotechnologies Inc and owns about 4,767 shares of Adverum Biotechnologies Inc (ADVM) stock worth over $36,229. Details can be seen in Setareh Seyedkazemi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Setareh Seyedkazemi has not made any transactions after 2023-09-15 and currently still holds the listed stock(s).

Transaction Summary of Setareh Seyedkazemi

To

Setareh Seyedkazemi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Setareh Seyedkazemi owns 1 companies in total, including Adverum Biotechnologies Inc (ADVM) .

Click here to see the complete history of Setareh Seyedkazemi’s form 4 insider trades.

Insider Ownership Summary of Setareh Seyedkazemi

Ticker Comapny Transaction Date Type of Owner
ADVM Adverum Biotechnologies Inc 2023-09-15 Chief Development Officer

Setareh Seyedkazemi Latest Holdings Summary

Setareh Seyedkazemi currently owns a total of 1 stock. Setareh Seyedkazemi owns 4,767 shares of Adverum Biotechnologies Inc (ADVM) as of September 15, 2023, with a value of $36,229.

Latest Holdings of Setareh Seyedkazemi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADVM Adverum Biotechnologies Inc 2023-09-15 4,767 7.60 36,229

Holding Weightings of Setareh Seyedkazemi


Setareh Seyedkazemi Form 4 Trading Tracker

According to the SEC Form 4 filings, Setareh Seyedkazemi has made a total of 3 transactions in Adverum Biotechnologies Inc (ADVM) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Adverum Biotechnologies Inc is the sale of 620 shares on September 15, 2023, which brought Setareh Seyedkazemi around $9,426.

Insider Trading History of Setareh Seyedkazemi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Setareh Seyedkazemi Trading Performance

GuruFocus tracks the stock performance after each of Setareh Seyedkazemi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Setareh Seyedkazemi is 51.33%. GuruFocus also compares Setareh Seyedkazemi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Setareh Seyedkazemi within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Setareh Seyedkazemi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Setareh Seyedkazemi

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 30.75
Relative Return to S&P 500(%) 35.23

Setareh Seyedkazemi Ownership Network

Ownership Network List of Setareh Seyedkazemi

No Data

Ownership Network Relation of Setareh Seyedkazemi


Setareh Seyedkazemi Owned Company Details

What does Adverum Biotechnologies Inc do?

Who are the key executives at Adverum Biotechnologies Inc?

Setareh Seyedkazemi is the Chief Development Officer of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Financial Officer Linda M Rubinstein , Chief Scientific Officer Brigit Riley , and director & CEO and Director Laurent Fischer .

Adverum Biotechnologies Inc (ADVM) Insider Trades Summary

Over the past 18 months, Setareh Seyedkazemi made 1 insider transaction in Adverum Biotechnologies Inc (ADVM) with a net sale of 6,201. Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adverum Biotechnologies Inc Insider Transactions

No Available Data

Setareh Seyedkazemi Mailing Address

Above is the net worth, insider trading, and ownership report for Setareh Seyedkazemi. You might contact Setareh Seyedkazemi via mailing address: C/o Adverum Biotechnologies, Inc., 100 Cardinal Drive, Redwood City Ca 94063.

Discussions on Setareh Seyedkazemi

No discussions yet.